// App-Quantinova.ai

PD-000 : COMPARISON OF KRAS MUTATION STATUS BETWEEN PRIMARY TUMORS AND CIRCULATING TUMOR CELLS IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)

Researchers

Presenter

  • Aristea Kalikaki

Principal Investigators

  • Helen Politaki

  • Maria Tzardi

  • Elisavet Papadimitraki

  • Demitris Mavroudis

  • John Souglakos

  • Alexandra Voutsina

  • Vassilis Georgoulias

Medical Centers

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete and Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Greece

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece

  • Laboratory of Pathology, University General Hospital of Heraklion, Heraklion, Greece

  • Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • Circulating tumor cells

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved